Every SEC Form 3/4/5 on record for this filer (CIK 1682093) — 6 issuers, 30 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | 10% owner | 2020-09-17 → 2026-04-09 | 8 | $7M |
| UPB | Upstream Bio, Inc. | Director | 2024-10-10 → 2024-10-17 | 2 | — |
| GLTO | Galecto, Inc. | 10% owner · lapsed | 2020-10-28 → 2023-08-17 | 9 | −$1M |
| ETNB | 89bio, Inc. | 10% owner · lapsed | 2019-11-08 → 2022-01-27 | 4 | $13M |
| LOGC | LogicBio Therapeutics, Inc. | Director · lapsed | 2018-10-18 → 2020-10-05 | 3 | — |
| STDY | SteadyMed Ltd. | 10% owner · lapsed | 2016-08-12 → 2018-09-07 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ACET | 2026-04-08 | Sell | 40,416 | $6.52 | $263,512 | — |
| ACET | 2026-04-08 | Sell | 32,523 | $6.29 | $204,570 | — |
| ACET | 2026-04-07 | Sell | 2,400 | $6.38 | $15,312 | 32,523 |
| ACET | 2026-04-07 | Sell | 29,319 | $6.53 | $191,453 | 34,923 |
| ACET | 2024-01-25 | Buy | 1,841,100 | $2.40 | $4M | 7,526,359 |
| ACET | 2024-01-25 | Buy | 1,041,700 | $2.40 | $3M | 1,255,985 |
| ACET | 2024-01-25 | Buy | 242,200 | $2.40 | $581,280 | 990,254 |
| GLTO | 2023-08-15 | Sell | 248,819 | $0.75 | $186,614 | 631,048 |
| GLTO | 2023-08-15 | Sell | 38,327 | $0.75 | $28,745 | 97,204 |
| GLTO | 2023-08-15 | Sell | 535,534 | $0.75 | $401,651 | 1,510,375 |
2 of 6 issuers are covered and open a security page; the rest are on file here only.
